Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy-Reference-Cited by-同舟云学术

Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy

Published:2021-07 Issue:4 Volume:35 Page:1929-1934
ISSN:0891-6640
Container-title:Journal of Veterinary Internal Medicine
language:en
Short-container-title:J Vet Intern Med

Author:

Faulhaber Erica A.¹^ORCID,Janik Emily¹,Thamm Douglas H.¹^ORCID

Affiliation:

1. Flint Animal Cancer Center, Department of Clinical Sciences Colorado State University Fort Collins Colorado USA

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvim.16212

Reference35 articles.

1. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001–2012)

2. A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma

3. Chemotherapy of Canine Hemangiosarcoma With Doxorubicin and Cyclophosphamide

4. Surgery and Doxorubicin in Dogs With Hemangiosarcoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemangiosarcoma of pets: a literary review;Russian veterinary journal;2024-09-03

2. Improved predictability is needed for calculators used to preoperatively determine the etiology of splenic masses in dogs: an external validation study of the HeLP score and T-STAT;Journal of the American Veterinary Medical Association;2024-04-16

3. Prognostic impact of Ki-67 in canine splenic hemangiosarcoma: A preliminary study;Veterinary Pathology;2024-01-12

4. Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer;Veterinary Pathology;2023-10-31

5. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma;Veterinary and Comparative Oncology;2023-09-21